Clinical Trial: Study on Risk Factors and Prognosis of MASLD

U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433205) titled 'Study on Risk Factors and Prognosis of MASLD' on Feb. 20.

Brief Summary: This longitudinal cohort study will enroll individuals with MASLD (and/or those at risk) and follow them over time to identify clinical and metabolic risk factors for disease progression and to evaluate predictors of long-term outcomes, including fibrosis progression and liver-related events, major cardiovascular events, and all-cause mortality.

Study Start Date: Jan. 01, 2024

Study Type: OBSERVATIONAL

Condition: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Recruitment Status: COMPLETED

Sponsor: First Affiliated Hospital of Chongqing M...